SNDX Nicholas A.j. Botwood bought Syndax Pharmaceuticals Inc shares — SEC Form 4BUYSyndax Pharmaceuticals Inc

Nicholas A.j. Botwood, Head of R&D, CMO at Syndax Pharmaceuticals Inc (SNDX), bought 11,765 shares at $9.00 ($106K) on 2025-05-16, disclosed to the SEC on 2025-05-19.

SEC EDGAR Filing

0000950170-25-074301

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Notable65/100

Something here stands out, but not much.

First-Time BuyerBuying the DipMajor Holdings Increase (>50%)Opportunistic BuyDeep Dip Buy

Trade Context

•Increased holdings by 50%
•Buying near 52-week low (+1% from bottom)
•Stock down -44% in previous 6 months

Filing Info

Filed2025-05-19

Traded2025-05-16

Accession0000950170-25-074301

SourceSEC EDGAR (Historical)

Insider

NameNicholas A.j. Botwood

TitleHead of R&D, CMO

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
SNDX	SELL	2026-06-12	$1.2M	—	Filing →

Get an email when an insider at SNDX files

Free account. Follow SNDX and up to 10 more companies.

Follow SNDX for free

SNDX Nicholas A.j. Botwood bought Syndax Pharmaceuticals Inc shares — SEC Form 4BUYSyndax Pharmaceuticals Inc

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes